NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Patients with high risk of relapse, ER+ and HER2- primary non-metastatic breast cancer who remain disease-free
1 total trials
Filter these 1 trials by phase, country, sponsor and more.